Infectious Disease Doctors in Idaho Falls, ID Accepting Medicare

5 Infectious Disease doctors found. Showing 1 - 5

Martha I Buitrago, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3614 Washington Pkwy, Idaho Falls, ID 83404 Phone: 208-535-8400    Fax: 208-535-8409

Mr. David Jon Pombo, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3200 Channing Way Ste 306, Idaho Falls, ID 83404 Phone: 208-535-4567

John Todd Bagwell, M.D. Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 3200 Channing Way Ste 306, Idaho Falls, ID 83404 Phone: 208-535-4475

Dr. Richard Alan Nathan, D.O. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3614 Washington Pkwy, Idaho Falls, ID 83404 Phone: 208-535-8400    Fax: 208-535-8409

Joyce Lynette Sanchez, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3200 Channing Way Ste 306, Idaho Falls, ID 83404 Phone: 208-535-4475    Fax: 208-535-4479

News Archive

Trauma patients likely to experience moderately severe pain 1 year after injuries

Most patients have moderately severe pain resulting from their injuries one year after sustaining major trauma, according to a report in the March issue of Archives of Surgery, one of the JAMA/Archives journals.

Gene editing of hematopoietic stem cells can cure many hereditary and congenital diseases

Recent advances in gene editing technology, which allows for targeted repair of disease-causing mutations, can be applied to hematopoietic stem cells with the potential to cure a variety of hereditary and congenital diseases.

Study of aldosterone antagonist usage among patients hospitalised with heart failure published

A study published today in JAMA (October 21) by Nancy M. Albert and colleagues, exploring aldosterone antagonist usage among US patients hospitalised with heart failure, found that only one-third of patients meeting current US Clinical Practice Guidelines criteria were actually being treated.

Chloride-restrictive intravenous strategy may decrease incidence of AKI among critically ill patients

In a pilot study assessing the effect of different levels of chloride in intravenous fluids administered to critically ill patients in an intensive care unit, restricting the amount of chloride administration was associated with a significant decrease in the incidence of acute kidney injury and the use of renal replacement therapy, according to a study in the October 17 issue of JAMA.

FDA allows KU Medical Center to begin clinical trial of novel cellular therapy for HR/SR aGvHD

The University of Kansas Medical Center announced that the U.S. Food and Drug Administration has cleared it to begin a first-in-human clinical trial of MSCTC-0010 in patients with de novo high-risk acute or steroid-refractory acute graft-versus-host disease (HR/SR aGvHD).

Read more Medical News

› Verified 5 days ago